NO20001668L - Anvendelse av et DNA-fragment, samt komplementære kjeder, derivater og deler derav - Google Patents

Anvendelse av et DNA-fragment, samt komplementære kjeder, derivater og deler derav

Info

Publication number
NO20001668L
NO20001668L NO20001668A NO20001668A NO20001668L NO 20001668 L NO20001668 L NO 20001668L NO 20001668 A NO20001668 A NO 20001668A NO 20001668 A NO20001668 A NO 20001668A NO 20001668 L NO20001668 L NO 20001668L
Authority
NO
Norway
Prior art keywords
derivatives
well
parts
dna fragment
variant
Prior art date
Application number
NO20001668A
Other languages
English (en)
Other versions
NO20001668D0 (no
NO310661B1 (no
Inventor
Peter Herrlich
Helmut Ponta
Ursula Guenthert
Siegfried Matzku
Achim Wenzel
Original Assignee
Kernforschungsz Karlsruhe
Universitot Karlsruhe
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20001668L publication Critical patent/NO20001668L/no
Application filed by Kernforschungsz Karlsruhe, Universitot Karlsruhe, Deutsches Krebsforsch filed Critical Kernforschungsz Karlsruhe
Publication of NO20001668D0 publication Critical patent/NO20001668D0/no
Publication of NO310661B1 publication Critical patent/NO310661B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20001668A 1990-05-07 2000-03-31 Anvendelse av et DNA-fragment, samt komplement¶re kjeder, derivater og deler derav NO310661B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4014510A DE4014510A1 (de) 1990-05-07 1990-05-07 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie
PCT/EP1991/000614 WO1991017248A1 (de) 1990-05-07 1991-03-30 Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie

Publications (3)

Publication Number Publication Date
NO20001668L true NO20001668L (no) 1993-05-06
NO20001668D0 NO20001668D0 (no) 2000-03-31
NO310661B1 NO310661B1 (no) 2001-08-06

Family

ID=6405813

Family Applications (3)

Application Number Title Priority Date Filing Date
NO924234A NO309770B1 (no) 1990-05-07 1992-11-04 DNA-fragment som koder for en del av et overflateproteins metastasedannende tumorceller; ekspresjonsvektor; transformert vertscelle; polypeptid for anvendelse i et in vitro system; antistoff; samt anvendelse av antistoffet
NO19980293A NO317154B1 (no) 1990-05-07 1998-01-23 Fremgangsmate til fremstilling av et polypeptid
NO20001668A NO310661B1 (no) 1990-05-07 2000-03-31 Anvendelse av et DNA-fragment, samt komplement¶re kjeder, derivater og deler derav

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO924234A NO309770B1 (no) 1990-05-07 1992-11-04 DNA-fragment som koder for en del av et overflateproteins metastasedannende tumorceller; ekspresjonsvektor; transformert vertscelle; polypeptid for anvendelse i et in vitro system; antistoff; samt anvendelse av antistoffet
NO19980293A NO317154B1 (no) 1990-05-07 1998-01-23 Fremgangsmate til fremstilling av et polypeptid

Country Status (21)

Country Link
US (3) US5506119A (no)
EP (1) EP0531300B1 (no)
JP (1) JP3133062B2 (no)
KR (1) KR0184691B1 (no)
AT (1) ATE106943T1 (no)
AU (1) AU646858B2 (no)
BR (1) BR1100650A (no)
CA (1) CA2082382C (no)
DE (2) DE4014510A1 (no)
DK (1) DK0531300T3 (no)
FI (1) FI106128B (no)
HU (1) HU218905B (no)
IE (1) IE62096B1 (no)
IL (3) IL134982A (no)
NO (3) NO309770B1 (no)
NZ (1) NZ238056A (no)
PT (1) PT97574B (no)
TW (1) TW212202B (no)
WO (1) WO1991017248A1 (no)
YU (1) YU49126B (no)
ZA (1) ZA913389B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002873A (en) * 1989-03-17 1991-03-26 Fred Hutchinson Cancer Research Center DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
DE4134982A1 (de) * 1991-10-23 1993-04-29 Kernforschungsz Karlsruhe Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
DE69302276T2 (de) * 1992-07-21 1996-09-19 Isis Innovation Diagnostische Methode
JPH08511419A (ja) 1993-06-18 1996-12-03 ヤルカネン、シルパ 組成物およびＣＤ４４ｖ６に対するモノクローナル抗体を用いる診断方法
DE4320623C2 (de) * 1993-06-22 1997-11-20 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Adenokarzinomen
EP0767378A1 (de) * 1993-06-22 1997-04-09 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Diagnose und Analyse von Magenkarzinomen
DE4320624A1 (de) * 1993-06-22 1995-02-09 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Mammakarzinomen
DE4326573A1 (de) * 1993-08-07 1995-02-23 Boehringer Ingelheim Int Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren
DE4431297A1 (de) * 1994-09-02 1996-03-07 Boehringer Ingelheim Int Monoklonaler Antikörper gegen CD44v6
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
DE19653607A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Int Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen
DE19708713C2 (de) * 1997-03-04 2002-11-28 Boehringer Ingelheim Int Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen
US20080124327A1 (en) * 1999-10-08 2008-05-29 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8048416B2 (en) 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) * 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8071072B2 (en) 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20090004103A1 (en) * 1999-10-08 2009-01-01 Young David S F Cytotoxicity mediation of cells evidencing surface expression of CD44
DE10026833A1 (de) * 2000-05-30 2001-12-13 Karlsruhe Forschzent Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens
AU2003272511A1 (en) * 2002-09-13 2004-04-30 Dyax Corporation Cd44-binding ligands
PL2886126T3 (pl) 2013-12-23 2017-11-30 Exchange Imaging Technologies Gmbh Nanocząstka sprzężona z peptydami wiążącymi CD44
CN109608537B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p2及其应用
CN109608536B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p3及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
US5108904A (en) * 1990-03-26 1992-04-28 Alan Landay CD44 as a marker for HIV infection

Also Published As

Publication number Publication date
NO924234L (no) 1993-01-04
FI925043A0 (fi) 1992-11-06
AU646858B2 (en) 1994-03-10
NO20001668D0 (no) 2000-03-31
IL98024A0 (en) 1992-06-21
YU49126B (sh) 2004-03-12
NZ238056A (en) 1993-01-27
NO924234D0 (no) 1992-11-04
NO980293D0 (no) 1998-01-23
DE4014510A1 (de) 1991-11-14
EP0531300A1 (de) 1993-03-17
TW212202B (no) 1993-09-01
US5760178A (en) 1998-06-02
NO310661B1 (no) 2001-08-06
IE62096B1 (en) 1995-01-11
WO1991017248A1 (de) 1991-11-14
HU9203449D0 (en) 1993-01-28
PT97574A (pt) 1992-01-31
FI106128B (fi) 2000-11-30
US5506119A (en) 1996-04-09
CA2082382C (en) 2008-09-30
JP3133062B2 (ja) 2001-02-05
PT97574B (pt) 1998-08-31
IE911526A1 (en) 1991-11-20
FI925043A (fi) 1992-11-06
NO317154B1 (no) 2004-08-30
IL98024A (en) 2001-06-14
KR0184691B1 (ko) 1999-04-01
IL134982A (en) 2004-05-12
NO309770B1 (no) 2001-03-26
DK0531300T3 (da) 1994-10-10
ZA913389B (en) 1992-03-25
JPH05508309A (ja) 1993-11-25
HUT63652A (en) 1993-09-28
CA2082382A1 (en) 1991-11-08
DE59101889D1 (de) 1994-07-14
IL134982A0 (en) 2001-05-20
BR1100650A (pt) 2000-08-08
YU79491A (sh) 1994-06-10
EP0531300B1 (de) 1994-06-08
ATE106943T1 (de) 1994-06-15
US5885575A (en) 1999-03-23
HU218905B (hu) 2000-12-28
NO980293L (no) 1993-01-04
AU7565991A (en) 1991-11-27

Similar Documents

Publication Publication Date Title
NO20001668L (no) Anvendelse av et DNA-fragment, samt komplementære kjeder, derivater og deler derav
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
IL100343A0 (en) G protein coupled glutamate receptors
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
SI1346034T1 (sl) POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
ATE106454T1 (de) Kennzeichnung und nachweis von mit autoimmunkrankheiten assoziierten sequenzen.
EP0546087A4 (no)
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
ATE166231T1 (de) Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.